Skip to content

Author

Shukun Chen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Coptisine Protects Against Cisplatin-Induced Acute Kidney Injury With Involvement of PI3K/Akt Signaling.

Cisplatin is an effective chemotherapeutic agent whose clinical use is limited by nephrotoxicity. This study investigated the protective effects of coptisine, a bioactive alkaloid from Coptis chinensis, against cisplatin-induced acute kidney injury (AKI). Network pharmacology was used to predict potential targets and p...

Chun-Yan Liu, Shu-Kun Chen, Ya-Ting He et al. · 0 citations
Aug 2026

Huangkui Capsule Effects in IgAN Through TLR4-Mediated Inflammatory Signaling.

Globally, immunoglobulin A (IgA) nephropathy (IgAN) is diagnosed more frequently than any other primary glomerular disorder and contributes substantially to the development of chronic kidney disease and end-stage renal disease. Although the Huangkui capsule, derived from Abelmoschus manihot, has demonstrated renoprotec...

Shukun Chen, Yan-Jun He, Ye Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.